|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Roy V and Perez EA: Biologic therapy of
breast cancer: focus on co-inhibition of endocrine and angiogenesis
pathways. Breast Cancer Res Treat. 116:31–38. 2009. View Article : Google Scholar
|
|
3
|
Geisler J: Differences between the
non-steroidal aromatase inhibitors anastrozole and letrozole - of
clinical importance. Br J Cancer. 104:1059–1066. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Brodie A, Sabnis G and Macedo L: Xenograft
models for aromatase inhibitor studies. J Steroid Biochem Mol Biol.
106:119–124. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nabholtz JM, Mouret-Reynier MA, Durando X,
Van Praagh I, Al-Sukhun S, Ferriere JP and Chollet P: Comparative
review of anastrozole, letrozole and exemestane in the management
of early breast cancer. Expert Opin Pharmacother. 10:1435–1447.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Miller WR and Larionov AA: Understanding
the mechanisms of aromatase inhibitor resistance. Breast Cancer
Res. 14:2012012. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sun X, Jiao X, Pestell TG, Fan C, Qin S,
Mirabelli E, Ren H and Pestell RG: MicroRNAs and cancer stem cells:
the sword and the shield. Oncogene. 33:4967–4977. 2014. View Article : Google Scholar
|
|
8
|
Sun X, Qin S, Fan C, Xu C, Du N and Ren H:
Let-7: a regulator of the ERα signaling pathway in human breast
tumors and breast cancer stem cells. Oncol Rep. 29:2079–2087. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sun X, Tang S-C, Xu C, Wang C, Qin S, Du
N, Liu J, Zhang Y, Li X and Luo G: DICER1 regulated let-7
expression levels in p53-induced cancer repression requires cyclin
D1. J Cell Mol Med. 19:1357–1365. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sun Xu C, Qin X, Wang S, Zheng H, Xu Z,
Luo S, Liu G, Liu P, Du JN, et al: Let-7a regulates mammosphere
formation capacity through Ras/NF-κB and Ras/MAPK/ERK pathway in
breast cancer stem cells. Cell Cycle. 14:1686–1697. 2015.
View Article : Google Scholar
|
|
11
|
Sun X, Jiang S, Liu J, Wang H, Zhang Y,
Tang SC, Wang J, Du N, Xu C, Wang C, et al: miR-208a stimulates the
cocktail of SOX2 and β-catenin to inhibit the let-7 induction of
self-renewal repression of breast cancer stem cells and formed
miR208a/let-7 feedback loop via LIN28 and DICER1. Oncotarget.
6:32944–32954. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sun X, Liu J, Xu C, Tang SC and Ren H: The
insights of Let-7 miRNAs in oncogenesis and stem cell potency. J
Cell Mol Med. 20:1779–1788. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sun X, Xu C, Tang SC, Wang J, Wang H, Wang
P, Du N, Qin S, Li G, Xu S, et al: Let-7c blocks estrogen-activated
Wnt signaling in induction of self-renewal of breast cancer stem
cells. Cancer Gene Ther. 23:83–89. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang T, Liu Z, Guo S, Wu L, Li M, Yang J,
Chen R, Xu H, Cai S, Chen H, et al: The tumor suppressive role of
CAMK2N1 in castration-resistant prostate cancer. Oncotarget.
15:3611–3621. 2014.
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
16
|
Liu H, Liang Y, Li Y, Li Y, Wang J, Wu H,
Wang Y, Tang SC, Chen J and Zhou Q: Gene silencing of BAG-1
modulates apoptotic genes and sensitizes lung cancer cell lines to
cisplatin-induced apoptosis. Cancer Biol Ther. 9:832–840. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
He J, Wang M, Jiang Y, Chen Q, Xu S, Xu Q,
Jiang BH and Liu LZ: Chronic arsenic exposure and angiogenesis in
human bronchial epithelial cells via the
ROS/miR-199a5p/HIF-1α/COX-2 pathway. Environ Health Perspect.
122:255–261. 2014.PubMed/NCBI
|
|
18
|
Wang T, Guo S, Liu Z, Wu L, Li M, Yang J,
Chen R, Liu X, Xu H, Cai S, et al: CAMK2N1 inhibits prostate cancer
progression through androgen receptor-dependent signaling.
Oncotarget. 5:10293–10306. 2014.PubMed/NCBI
|
|
19
|
Qin S, Yang C, Zhang B, Li X, Sun X, Li G,
Zhang J, Xiao G, Gao X, Huang G, et al: XIAP inhibits mature
Smac-induced apoptosis by degrading it through ubiquitination in
NSCLC. Int J Oncol. 49:1289–1296. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qin S, Xu C, Li S, Wang X, Sun X, Wang P,
Zhang B and Ren H: Hyperthermia induces apoptosis by targeting
survivin in esophageal cancer. Oncol Rep. 34:2656–2664. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sun Y, Wang Y, Fan C, Gao P, Wang X, Wei G
and Wei J: Estrogen promotes stemness and invasiveness of
ER-positive breast cancer cells through Gli1 activation. Mol
Cancer. 13:1372014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ginestier C, Hur MH, Charafe-Jauffret E,
Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG,
Liu S, et al: ALDH1 is a marker of normal and malignant human
mammary stem cells and a predictor of poor clinical outcome. Cell
Stem Cell. 1:555–567. 2007. View Article : Google Scholar
|
|
23
|
Liu SY and Zheng PS: High aldehyde
dehydrogenase activity identifies cancer stem cells in human
cervical cancer. Oncotarget. 4:2462–2475. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang T, Liu Z, Guo S, Wu L, Li M, Yang J,
Chen R, Xu H, Cai S, Chen H, et al: The tumor suppressive role of
CAMK2N1 in castration-resistant prostate cancer. Oncotarget.
5:3611–3621. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang T, Guo S, Liu Z, Wu L, Li M, Yang J,
Chen R, Liu X, Xu H, Cai S, et al: CAMK2N1 inhibits prostate cancer
progression through androgen receptor-dependent signaling.
Oncotarget. 5:10293–10306. 2014.PubMed/NCBI
|
|
26
|
Dhami GK, Liu H, Galka M, Voss C, Wei R,
Muranko K, Kaneko T, Cregan SP, Li L and Li SS: Dynamic methylation
of Numb by Set8 regulates its binding to p53 and apoptosis. Mol
Cell. 50:565–576. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Renoir J-M, Marsaud V and Lazennec G:
Estrogen receptor signaling as a target for novel breast cancer
therapeutics. Biochem Pharmacol. 85:449–465. 2013. View Article : Google Scholar
|
|
28
|
Maczis M, Milstien S and Spiegel S:
Sphingosine-1-phosphate and estrogen signaling in breast cancer.
Adv Biol Regul. 60:160–165. 2016. View Article : Google Scholar
|
|
29
|
Ward A, Shukla K, Balwierz A, Soons Z,
König R, Sahin O and Wiemann S: MicroRNA-519a is a novel oncomir
conferring tamoxifen resistance by targeting a network of
tumour-suppressor genes in ER+ breast cancer. J Pathol.
233:368–379. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ward A, Balwierz A, Zhang JD, Küblbeck M,
Pawitan Y, Hielscher T, Wiemann S and Sahin Ö: Re-expression of
micro RNA-375 reverses both tamoxifen resistance and accompanying
EMT-like properties in breast cancer. Oncogene. 32:1173–1182. 2013.
View Article : Google Scholar
|
|
31
|
Miller TE, Ghoshal K, Ramaswamy B, Roy S,
Datta J, Shapiro CL, Jacob S and Majumder S: MicroRNA-221/222
confers tamoxifen resistance in breast cancer by targeting
P27Kip1. J Biol Chem. 283:29897–29903. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Han Li C and Chen Y: Small and long
non-coding RNAs: novel targets in perspective cancer therapy. Curr
Genomics. 16:319–326. 2015. View Article : Google Scholar
|
|
33
|
Crea F, Watahiki A, Quagliata L, Xue H,
Pikor L, Parolia A, Wang Y, Lin D, Lam WL, Farrar WL, et al:
Identification of a long non-coding RNA as a novel biomarker and
potential therapeutic target for metastatic prostate cancer.
Oncotarget. 5:764–774. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen ZZ, Huang L, Wu YH, Zhai WJ, Zhu PP
and Gao YF: LncSox4 promotes the self-renewal of liver
tumour-initiating cells through Stat3-mediated Sox4 expression. Nat
Commun. 7:125982016. View Article : Google Scholar : PubMed/NCBI
|
